For Research Use Only.

Tesamorelin is a synthetic peptide analog of growth hormone-releasing hormone (GHRH),
commonly studied for its role in stimulating the natural release of growth hormone (GH) via
pituitary pathways. It has been referenced in literature for its effects on fat metabolism, body
composition, and age-related physiological changes.

Key Characteristics
• Type: Synthetic GHRH analog
• Research Synonym: Associated in clinical studies with the compound “Egrifta”
• Format: Subcutaneous research peptide
• Half-life: ~2 hours (noted for pulsatile GH release stimulation)

Mechanism of Interest (Based on Research)
• Binds to GHRH receptors in the pituitary gland
• Stimulates endogenous growth hormone (GH) secretion
• Investigated for impact on lipolysis, body composition, and protein synthesis pathways

Research Focus Areas
• Visceral Fat Metabolism Models
• Muscle Tissue Maintenance and Development
• GH-Related Aging Biomarkers

• Metabolic Health and Fat Redistribution Studies

Notable Observations in Literature
• Studied for effects on abdominal adiposity in specific clinical populations
• Evaluated for its role in promoting lean muscle mass
• Some research interest in skin structure and elasticity via GH-mediated collagen pathways
• Explored in relation to energy regulation and metabolic efficiency

Reported Research Effects
• Reduction in visceral fat volume (in controlled environments)• Increases in lean body mass
and improved body composition marker• Investigated for influence on skin appearance,
vitality, and GH-related pathways